(Q28588181)

Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

21 April 2017

1 reference

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 April 2017

1 reference

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

21 April 2017

1 reference

VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain

21 April 2017

1 reference

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 April 2017

1 reference

Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis

21 April 2017

1 reference

Disruption of epithelial cell-matrix interactions induces apoptosis

21 April 2017

1 reference

The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin

21 April 2017

1 reference

Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin

21 April 2017

1 reference

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors

21 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

VEGF-C, a lymphatic growth factor, is a RANKL target gene in osteoclasts that enhances osteoclastic bone resorption through an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

VEGF-C promotes survival in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Current biology of VEGF-B and VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Genomic organization of human and mouse genes for vascular endothelial growth factor C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Control of adhesion-dependent cell survival by focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Anchorage dependence, integrins, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

The extracellular matrix as a cell survival factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Nucleolin: a multiFACeTed protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100379